Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-422 Cr₹818 Cr₹794 Cr₹3,977 Cr

What is the latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA is ₹-422 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-422 Cr
Mar2023₹818 Cr
Mar2022₹794 Cr
Mar2021₹3,977 Cr

How is Cash Flow from Financing Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-422 Cr
Negative
Mar2023 ₹818 Cr
2.97
Mar2022 ₹794 Cr
-80.03
Mar2021 ₹3,977 Cr -

Compare Cash Flow from Financing Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹26,610.6 Cr -3.1% -8.7% 36.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,176.0 Cr 0.4% -1.2% 12.2% Stock Analytics
DIVIS LABORATORIES ₹177,076.0 Cr 2.6% 8.4% 48.5% Stock Analytics
CIPLA ₹121,592.0 Cr -0.1% 0.5% 1.7% Stock Analytics
DR REDDYS LABORATORIES ₹113,615.0 Cr 3.2% 11.8% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,024.0 Cr 3.4% 0.5% 12.8% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-3.1%

-8.7%

36.3%

SENSEX

-1.3%

-0.3%

5.8%


You may also like the below Video Courses